Lingohr & Partner Asset Management GmbH »

Catalyst Pharmaceutical Partners shares owned by Lingohr & Partner Asset Management GmbH

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Lingohr & Partner Asset Management GmbH from 13F filings

Historical chart of Lingohr & Partner Asset Management GmbH investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Lingohr & Partner Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Lingohr & Partner Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-12-31 $202k 9.6k 21.02

More positions owned by Lingohr & Partner Asset Management GmbH

Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
Alphabet Inc Class A cs (GOOGL)
Exelixis (EXEL)
Netflix (NFLX)
Ubs Group (UBS)
Flextronics International Ltd Com Stk (FLEX)
Nortonlifelock (GEN)
Facebook Inc cl a (META)
Mueller Industries (MLI)
Technipfmc (FTI)
Dell Technologies (DELL)
Lam Research (LRCX)
Advanced Micro Devices (AMD)
Thermo Fisher Scientific (TMO)

View all positions for Lingohr & Partner Asset Management GmbH

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners